4-Alkyl- and 3,4-dialkyl-1,2,3,4,-tetrahydro-8-pyridono[5,6-g]quinolines: Potent, nonsteroidal androgen receptor agonists
- 1 May 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (9) , 1335-1340
- https://doi.org/10.1016/s0960-894x(99)00186-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)Journal of Medicinal Chemistry, 1999
- Discovery of Nonsteroidal AndrogensBiochemical and Biophysical Research Communications, 1998
- Synthesis and Biological Activity of a Novel Series of Nonsteroidal, Peripherally Selective Androgen Receptor Antagonists Derived from 1,2-Dihydropyridono[5,6-g]quinolinesJournal of Medicinal Chemistry, 1998
- Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal MenJournal of Clinical Endocrinology & Metabolism, 1997
- Androgens in Men — Uses and AbusesNew England Journal of Medicine, 1996
- Ring construction by zirconium-promoted reductive coupling of nitrites with alkenesJournal of the Chemical Society, Chemical Communications, 1990
- Studies of reduction with the sodium borohydride-transition metal boride system. I. Reduction of nitro and the other functional groups with the sodium borohydride-nickel boride system.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- Hepatotoxic Effects of the Anabolic/Androgenic SteroidsSeminars in Liver Disease, 1987
- Toxicity of methyl testosterone in the beagle dogToxicology, 1977
- Evidence for Changes in Sensitivity to Testosterone Negative Feedback on Gonadotropin Release During Sexual Development in the Male RatEndocrinology, 1973